Micro-Sphere pumps $22m into capsule filling facility

By Flora Southey

- Last updated on GMT


Related tags Supply and demand Manufacturing

Spray drying and capsule filling-focused Micro-Sphere is expanding manufacturing capabilities at its facility in Ticino, Switzerland.

The firm is investing 21m CHF ($21.7m) in the site, which will see the 1,415m² facility expand to 2,905m².

Managing director Stefano Console told us the decision to expand came from growing market demand, predominantly in Europe and North America.

The company’s founder Michele Müller also observed an increased demand for fill & finish services.

“Both GMP spray drying as a particle engineering technique and low dose capsule filling are becoming increasingly popular across the market and at present there are very few CDMOs ​[contract development and manufacturing organisations] offering this level of capability,” ​said Müller.

“From our expanded facility, we will continue to produce both clinical and commercial products, with a particular specialism in dry powder inhalers,” ​he added.

New business & jobs

Console said he expects the increased GMP capabilities to increase the company’s client base, which currently includes firms in the US, Europe, New Zealand and Asia.

“The expansion is already attracting new business, and we expect this to continue in the coming months,”​ he said.

The expanded facility - expected to be operational by Q4 2017 - will create 20 new roles, he told us.

Related news

Related products

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 04-May-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Follow us


View more